US20040141151A1 - More easily visualized punctum plug configurations - Google Patents
More easily visualized punctum plug configurations Download PDFInfo
- Publication number
- US20040141151A1 US20040141151A1 US10/754,670 US75467004A US2004141151A1 US 20040141151 A1 US20040141151 A1 US 20040141151A1 US 75467004 A US75467004 A US 75467004A US 2004141151 A1 US2004141151 A1 US 2004141151A1
- Authority
- US
- United States
- Prior art keywords
- plug
- eye
- person
- light
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00772—Apparatus for restoration of tear ducts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Definitions
- This invention relates generally to the punctum plug and in particular, to plugs and apparatus which enable a plug to be more easily visualized following insertion.
- Tears are provided to the human eye to lubricate them, supply nutrients and guard against environmental contaminants.
- the tears are secreted by the lachrymal gland, and the excess fluid is carried away by lachrymal or punctal canals into the lachrymal sac, and along the nasal duct into the cavity of the nose.
- a condition called “dry eye” may occur when inadequate tears are produced. Generally, this is the result of improper body chemistry, injury, or the aging process. This condition may affect either or both of the eyes and causes the eyes to feel scratchy and irritated. Artificial eye drops may provide temporary relief from the problem, but a long term solution is desirable.
- One long-term solution involves the reversible closing of one of the drain ducts of the affect eye. This is done by inserting a plug into one of the ducts, or punctual canals. Typically, this is a clinical procedure requiring less than a half hour.
- a problem often arises after the plug is inserted because the body may eject the plug from the canal, or it may be “rubbed out” by the recipient. In either event, the value of the treatment is lost. Therefore, the recipient has great interest in knowing the plug remains in place.
- the plug is extremely small, generally being less than a millimeter in diameter and a millimeter or so in length, it is very difficult to see. Also, the plug is made all the more difficult to see because it is currently made of Silastic rubber that is naturally flesh colored and translucent and is therefore not easily seen. It is the objects of this invention to make the punctum plug readably visible or detectable to the recipient or caregiver, and thereby help the recipient determine that the plug remains properly in place.
- a plug according to the invention includes a body having an outwardly exposed surface when properly positioned, and a substance causing at least the outwardly exposed surface to contrast with surrounding tissue, such that the use of the substance causes the plug to be more easily visualized than if the substance were not present.
- the rest of the plug body may be composed of any suitable material, including those presently used in the manufacture of such devices.
- the substance which may be disposed on the outwardly exposed surface or within the body of the plug, may include a saturated coloration, or may be phosphorescent, fluorescent or otherwise operative to reflect or re-radiate light to assist in visualization.
- the substance may include an organic or inorganic phosphor or fluorescent material, reflective beads, quantum dots, a dye or pigment. Such reflection or re-radiation may occur at the same or different wavelength(s) compared to the illumination wavelength(s), whether or not either or both are within the visible part of the spectrum.
- a detector may be employed according to the invention for detecting the radiated light.
- a system for determining whether or not a punctum plug is positioned within the punctal canal of a person's eye is also enclosed, including at least one optical element permitting the eye to view itself, to be viewed by the other eye, or by a second person.
- FIG. 1 is a schematic diagram of an optical aid and accompanying method according to the invention for viewing a punctum plug without interference from illumination from a primary source;
- FIG. 2 is a schematic diagram of an optical aid and accompanying method according to the invention for viewing a punctum plug using the same eye into which the plug has been installed.
- this invention resides in punctum plug configurations which are more easily visualized, preferably allowing the presence and position of the plug to be seen by another person or by the recipient in a mirror.
- at least the outwardly exposed surface of the plug, or the entire plug body is pigmented to contrast with surrounding tissue.
- the exposed surface or plug body may be black or a saturated fluorescent color to create a more defined visual contrast.
- the end of the plug or entire body is coated with, or otherwise contains a fluorescent dye, phosphor, phosphorescent pigment, reflective beads, quantum dots, or other material allowing the plug to be more easily visualized with appropriate illumination.
- the plug preferably glows in the visible spectrum, though optical detectors such as a photodetector may be used if the light is outside the visible range.
- Additives applicable to the invention include, but are not limited to, fluorescent and phosphorescent materials, including organic, inorganic and rare-earth phosphors, internally reflecting (i.e., TIR) beads, quantum dots, dyes and pigments.
- the source of illumination may be violet or ultraviolet light, or other wavelengths chosen to cause a suitable or desired excited radiation or reflection.
- a fluorescent lamp, light-emitting diode, hot filament or other source may be used, along with filters, beam splitters, or other optical components, as appropriate,
- such a device may consist of an illumination source, a beam splitting mirror, and a magnifying lens arranged such that the light from the source is separated from the light returned from the beads or dots to the eye.
- the device may be constructed such that one eye inspects the other or, through appropriate optics, the same eye.
- the combination of visible light lamp and a magnifying viewer may be used to permit the eye to view itself, be viewed by the other eye, or viewed by a second person. If different illumination and response/reflective wavelengths are used, appropriate filtering may be employed to block or separate the reflected or re-radiated wavelength(s) from the illumination wavelength(s).
- FIGS. 1 and 2 are schematic diagrams which illustrate optical aids and accompanying methods according to the invention for viewing punctum plugs according to the invention regardless of whether the plug retransmits light of a different wavelength or passively reflects light of the same wavelength.
- the following legend is used:
- FIG. 1 For FIG. 1:
- M 1 mirror-filter, reflect ⁇ , pass ⁇ >
- P punctum plug, possessing excitable agent, or non-excitable
- E 1 recipient's eye under inspection
- E 2 recipient's other eye
- E 3 caregiver's eye
- S 2 plug illuminating source, broad flood, preferably close to eye
- L 3 spot forming lens
- L 2 eye imaging lens, preferably plano-convex
- M 4 mirror, close to L 2 , or deposit on rear of L 2
- FIG. 1 light from source S is reflected off element M 1 illuminating plug P.
- Light radiated by the plug P passes through element M 1 and is magnified by lens L. If a caregiver is the only individual responsible for viewing the plug, light magnified by L may be viewed directly, without the need for M 2 or M 3 .
- mirrors M 2 and M 3 may be provided, with M 3 having first and second positions to switch between E 2 and E 3 .
- element M 1 may be any device operative to at least partially reflect illumination from the source and at least partially pass light reflected or emitted by the plug, and may therefore be a semi-silvered mirror, filter, simple beamsplitter, or any combination thereof.
- FIG. 2 is a drawing which illustrates a configuration enabling the same eye to view a plug inserted into that eye.
- a source S 2 preferably a circular source
- a light from source S 3 may be used, preferably along with spot forming lens L 3 .
- the light radiated or reflected by the plug is redirected to the same eye, E 1 , using reflector M 4 , preferably with an imaging lens L 2 to magnify the image.
Abstract
An improved punctum plug is more easily visualized when positioned within a punctual canal of a recipient. The body of the plug features an outwardly exposed surface when properly positioned, and a substance causing at least the outwardly exposed surface to contrast with surrounding tissue, such that the use of the substance causes the plug to be more easily visualized than if the substance were not present. The substance, which may be disposed on the outwardly exposed surface or within the body of the plug, may include a saturated coloration, or may be phosphorescent, fluorescent or otherwise operative to reflect or re-radiate light to assist in visualization. For example, the substance may include an organic or inorganic phosphor or fluorescent material, reflective beads, quantum dots, a dye or pigment. Such reflection or re-radiation may occur at the same or different wavelength(s) compared to the illumination wavelength(s), whether or not either or both are within the visible part of the spectrum. If outside the visible region, a detector may be employed according to the invention for detecting the radiated light. A system for determining whether or not a punctum plug is positioned within the punctal canal of a person's eye is also enclosed, including at least one optical element permitting the eye to view itself, to be viewed by the other eye, or by a second person.
Description
- This application is a divisional of U.S. patent application Ser. No. 09/852,519, filed May 10, 2001, the entire content of which is incorporated herein by reference.
- This invention relates generally to the punctum plug and in particular, to plugs and apparatus which enable a plug to be more easily visualized following insertion.
- Tears are provided to the human eye to lubricate them, supply nutrients and guard against environmental contaminants. The tears are secreted by the lachrymal gland, and the excess fluid is carried away by lachrymal or punctal canals into the lachrymal sac, and along the nasal duct into the cavity of the nose.
- A condition called “dry eye” may occur when inadequate tears are produced. Generally, this is the result of improper body chemistry, injury, or the aging process. This condition may affect either or both of the eyes and causes the eyes to feel scratchy and irritated. Artificial eye drops may provide temporary relief from the problem, but a long term solution is desirable.
- One long-term solution involves the reversible closing of one of the drain ducts of the affect eye. This is done by inserting a plug into one of the ducts, or punctual canals. Typically, this is a clinical procedure requiring less than a half hour. However, a problem often arises after the plug is inserted because the body may eject the plug from the canal, or it may be “rubbed out” by the recipient. In either event, the value of the treatment is lost. Therefore, the recipient has great interest in knowing the plug remains in place.
- As the plug is extremely small, generally being less than a millimeter in diameter and a millimeter or so in length, it is very difficult to see. Also, the plug is made all the more difficult to see because it is currently made of Silastic rubber that is naturally flesh colored and translucent and is therefore not easily seen. It is the objects of this invention to make the punctum plug readably visible or detectable to the recipient or caregiver, and thereby help the recipient determine that the plug remains properly in place.
- This invention improves upon the existing art by providing a punctum plug which is more easily visualized when positioned within a punctual canal of a recipient. Broadly, a plug according to the invention includes a body having an outwardly exposed surface when properly positioned, and a substance causing at least the outwardly exposed surface to contrast with surrounding tissue, such that the use of the substance causes the plug to be more easily visualized than if the substance were not present. The rest of the plug body may be composed of any suitable material, including those presently used in the manufacture of such devices.
- The substance, which may be disposed on the outwardly exposed surface or within the body of the plug, may include a saturated coloration, or may be phosphorescent, fluorescent or otherwise operative to reflect or re-radiate light to assist in visualization. For example, the substance may include an organic or inorganic phosphor or fluorescent material, reflective beads, quantum dots, a dye or pigment. Such reflection or re-radiation may occur at the same or different wavelength(s) compared to the illumination wavelength(s), whether or not either or both are within the visible part of the spectrum.
- If outside the visible region, a detector may be employed according to the invention for detecting the radiated light. A system for determining whether or not a punctum plug is positioned within the punctal canal of a person's eye is also enclosed, including at least one optical element permitting the eye to view itself, to be viewed by the other eye, or by a second person.
- FIG. 1 is a schematic diagram of an optical aid and accompanying method according to the invention for viewing a punctum plug without interference from illumination from a primary source; and
- FIG. 2 is a schematic diagram of an optical aid and accompanying method according to the invention for viewing a punctum plug using the same eye into which the plug has been installed.
- Broadly, this invention resides in punctum plug configurations which are more easily visualized, preferably allowing the presence and position of the plug to be seen by another person or by the recipient in a mirror. In one preferred embodiment, at least the outwardly exposed surface of the plug, or the entire plug body, is pigmented to contrast with surrounding tissue. For example, unlike existing devices, the exposed surface or plug body may be black or a saturated fluorescent color to create a more defined visual contrast.
- In an alternative embodiment, the end of the plug or entire body is coated with, or otherwise contains a fluorescent dye, phosphor, phosphorescent pigment, reflective beads, quantum dots, or other material allowing the plug to be more easily visualized with appropriate illumination. In these embodiments, the plug preferably glows in the visible spectrum, though optical detectors such as a photodetector may be used if the light is outside the visible range.
- Additives applicable to the invention include, but are not limited to, fluorescent and phosphorescent materials, including organic, inorganic and rare-earth phosphors, internally reflecting (i.e., TIR) beads, quantum dots, dyes and pigments. The source of illumination may be violet or ultraviolet light, or other wavelengths chosen to cause a suitable or desired excited radiation or reflection. A fluorescent lamp, light-emitting diode, hot filament or other source may be used, along with filters, beam splitters, or other optical components, as appropriate,
- Although use of the invention preferably permits visualization with the unaided eye, the use of instruments such as magnifiers, ophthalmoscopes and counterparts thereof, are not precluded. For example, such a device may consist of an illumination source, a beam splitting mirror, and a magnifying lens arranged such that the light from the source is separated from the light returned from the beads or dots to the eye. The device may be constructed such that one eye inspects the other or, through appropriate optics, the same eye. For example, the combination of visible light lamp and a magnifying viewer may be used to permit the eye to view itself, be viewed by the other eye, or viewed by a second person. If different illumination and response/reflective wavelengths are used, appropriate filtering may be employed to block or separate the reflected or re-radiated wavelength(s) from the illumination wavelength(s).
- FIGS. 1 and 2 are schematic diagrams which illustrate optical aids and accompanying methods according to the invention for viewing punctum plugs according to the invention regardless of whether the plug retransmits light of a different wavelength or passively reflects light of the same wavelength. In the drawings, the following legend is used:
- For FIG. 1:
- M1=mirror-filter, reflect →, pass ˜>
- →=illumination, primary
- ˜>=fluorescence light
- P=punctum plug, possessing excitable agent, or non-excitable
- L=magnifying lens
- E1=recipient's eye under inspection
- E2=recipient's other eye
- E3=caregiver's eye
- M2=redirection mirror
- M3=rotating redirection mirror
- LS=light stop
- S=plug illumination source
- For FIG. 2:
- S2=plug illuminating source, broad flood, preferably close to eye
- S3=plug illumination source spot
- L3=spot forming lens
- L2=eye imaging lens, preferably plano-convex
- M4=mirror, close to L2, or deposit on rear of L2
- In FIG. 1, light from source S is reflected off element M1 illuminating plug P. Light radiated by the plug P passes through element M1 and is magnified by lens L. If a caregiver is the only individual responsible for viewing the plug, light magnified by L may be viewed directly, without the need for M2 or M3. However, in building an instrument which will allow either the same individual to view the plug with eye E2 or a caregiver to view the eye E3, mirrors M2 and M3 may be provided, with M3 having first and second positions to switch between E2 and E3. Note that element M1 may be any device operative to at least partially reflect illumination from the source and at least partially pass light reflected or emitted by the plug, and may therefore be a semi-silvered mirror, filter, simple beamsplitter, or any combination thereof.
- FIG. 2 is a drawing which illustrates a configuration enabling the same eye to view a plug inserted into that eye. In this case, light from a source S2, preferably a circular source, illuminates the plug P with a light stop LS preferably being used to block direct light from S2 from reaching an observer. Alternatively, a light from source S3 may be used, preferably along with spot forming lens L3. In any case, the light radiated or reflected by the plug is redirected to the same eye, E1, using reflector M4, preferably with an imaging lens L2 to magnify the image.
Claims (13)
1. Apparatus for viewing a punctum plug illuminated by a source of light in a person's eye, comprising:
a lens for magnifying the image of the punctum plug;
at least one light redirecting element for presenting the magnified image of the plug to an eye of an observer; and
one or more optical element for blocking the light from the source of light from reaching the observer's eye.
2. A system for determining whether or not a punctum plug is positioned within the punctal canal of a person's eye, the system comprising:
the punctum plug of claim 1; and
at least one optical element permitting the eye to view itself, to be viewed by the other eye, or by a second person.
3. The system of claim 1 , wherein the optical element includes a source of light at one or more illumination wavelengths causing the plug to reflect or re-radiate light.
4. The system of claim 3 , wherein the light which is reflected or re-radiated by the plug occurs at one or more wavelengths which are different from the illumination wavelength or wavelengths.
5. The system of claim 4 , further including a filter to block or separate the reflected or re-radiated wavelength(s) from the illumination wavelength(s).
6. The system of claim 4 , further including a detector to detect the reflected or re-radiated wavelength(s).
7. The system of claim 1 , wherein the optical element includes a magnifier.
8. The system of claim 1 , wherein the optical element includes a beam splitter or mirror permitting the eye to view itself or to be viewed by the other eye, or by a second person.
9. The apparatus of claim 1 , including a plurality of light redirecting elements enabling the person to view the eye containing the plug by the person's other eye.
10. The apparatus of claim 1 , wherein the light redirecting element enables a person other than the person wearing the plug to view the plug.
11. The apparatus of claim 1 , wherein the light redirecting element enables the person wearing the plug to view the plug with the person's other eye.
12. The apparatus of claim 1 , wherein:
the light redirecting element is switchable between a first position, such that a person other than the person wearing the plug is able to view the plug; and
a first position, such that the person wearing the plug is able to view the plug with the person's other eye.
13. The apparatus of claim 1 , wherein:
the plug radiates light at a wavelength other than the one used for illumination; and
the optical element for blocking the light from the source includes a wavelength-selective filter.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/754,670 US20040141151A1 (en) | 2001-05-10 | 2004-01-09 | More easily visualized punctum plug configurations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/852,519 US6982090B2 (en) | 2001-05-10 | 2001-05-10 | More easily visualized punctum plug configurations |
US10/754,670 US20040141151A1 (en) | 2001-05-10 | 2004-01-09 | More easily visualized punctum plug configurations |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/852,519 Division US6982090B2 (en) | 2001-05-10 | 2001-05-10 | More easily visualized punctum plug configurations |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040141151A1 true US20040141151A1 (en) | 2004-07-22 |
Family
ID=25313542
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/852,519 Expired - Fee Related US6982090B2 (en) | 2001-05-10 | 2001-05-10 | More easily visualized punctum plug configurations |
US10/754,670 Abandoned US20040141151A1 (en) | 2001-05-10 | 2004-01-09 | More easily visualized punctum plug configurations |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/852,519 Expired - Fee Related US6982090B2 (en) | 2001-05-10 | 2001-05-10 | More easily visualized punctum plug configurations |
Country Status (1)
Country | Link |
---|---|
US (2) | US6982090B2 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050232972A1 (en) * | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
US20070243230A1 (en) * | 2006-03-31 | 2007-10-18 | Forsight Labs, Llc | Nasolacrimal Drainage System Implants for Drug Therapy |
US20090005702A1 (en) * | 2005-03-18 | 2009-01-01 | Deborah Zelinsky | Method for diagnosis and treatment of processing difficulties, integration problems, imbalances and abnormal postures |
US20090099626A1 (en) * | 2007-09-07 | 2009-04-16 | Qlt Plug Delivery, Inc. - Qpdi | Lacrimal implant detection |
US20090098584A1 (en) * | 2005-09-01 | 2009-04-16 | Bristol-Myers Squibb Company | Biomarkers and Methods for Determining Sensitivity to Vascular Endothelial growth factor Receptor-2 Modulators |
US20090105749A1 (en) * | 2007-09-07 | 2009-04-23 | Qlt Plug Delivery, Inc. - Qpdi | Insertion and extraction tools for lacrimal implants |
US20090104243A1 (en) * | 2007-09-07 | 2009-04-23 | Qlt Plug Delivery, Inc. - Qpdi | Drug cores for sustained release of therapeutic agents |
US20090104248A1 (en) * | 2007-09-07 | 2009-04-23 | Qlt Plug Delivery, Inc. -Qpdi | Lacrimal implants and related methods |
US20090118702A1 (en) * | 2004-07-02 | 2009-05-07 | Forsight Labs, Llc | Treatment Medium Delivery Device and Methods for Delivery of Such Treatment Mediums to the Eye Using such a Delivery Device |
US20090264861A1 (en) * | 2008-02-18 | 2009-10-22 | Qlt Plug Delivery, Inc. | Lacrimal implants and related methods |
US20090280158A1 (en) * | 2008-05-09 | 2009-11-12 | Qlt Plug Delivery, Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
US20100274204A1 (en) * | 2009-02-23 | 2010-10-28 | Qlt Plug Delivery, Inc. | Lacrimal implants and related methods |
US20110066067A1 (en) * | 2006-12-07 | 2011-03-17 | Deborah Zelinsky | Methods for Diagnosis and Treatment of Processing Difficulties, Integration Problems, Imbalances and Abnormal Postures |
US9132088B2 (en) | 2008-04-30 | 2015-09-15 | Mati Therapeutics Inc. | Composite lacrimal insert and related methods |
US9610271B2 (en) | 2011-08-29 | 2017-04-04 | Mati Therapeutics Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
WO2022241266A1 (en) * | 2021-05-14 | 2022-11-17 | Glaukos Corporation | Materials and methods for punctal plugs |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7404825B2 (en) * | 2001-06-11 | 2008-07-29 | Herrick Ii Robert S | Implant capable of forming a differential image in an eye |
US9972082B2 (en) | 2012-02-22 | 2018-05-15 | Veran Medical Technologies, Inc. | Steerable surgical catheter having biopsy devices and related systems and methods for four dimensional soft tissue navigation |
WO2017062770A1 (en) | 2015-10-08 | 2017-04-13 | Silverberg Noah | Punctal plug and bioadhesives |
DK3861985T3 (en) | 2020-02-06 | 2023-07-24 | Ocular Therapeutix Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES |
EP4252725A3 (en) | 2020-03-25 | 2023-11-22 | Ocular Therapeutix, Inc. | Ocular implant containing a tyrosine kinase inhibitor |
EP3973952B1 (en) | 2020-09-24 | 2024-02-14 | Ocular Therapeutix, Inc. | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2582227A (en) * | 1948-12-27 | 1952-01-15 | Frank W Brady | Eye examining device having concave mirror |
US3677620A (en) * | 1967-11-20 | 1972-07-18 | Joseph Bettencourt | Corrective mirror assembly |
US3887800A (en) * | 1973-12-19 | 1975-06-03 | Minnesota Mining & Mfg | Personal care viewer |
US3949750A (en) * | 1974-10-07 | 1976-04-13 | Freeman Jerre M | Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same |
US4507585A (en) * | 1981-09-18 | 1985-03-26 | Hitachi, Ltd. | Beam-indexing color picture tube arrangement |
US4682867A (en) * | 1985-04-02 | 1987-07-28 | Gould Herbert L | Apparatus for the self-examination of the human eye |
US4750831A (en) * | 1986-05-23 | 1988-06-14 | Vega L Eduardo | Apparatus and method for self-examination of the eye and surrounding facial areas |
US4902124A (en) * | 1988-09-06 | 1990-02-20 | Roy Sr Frederick H | Cataract monitoring method and means |
US4959048A (en) * | 1989-01-17 | 1990-09-25 | Helix Medical, Inc. | Lacrimal duct occluder |
US4983846A (en) * | 1989-08-22 | 1991-01-08 | Arturo M. Rios | Portable fingerprint detection method and device |
US5178635A (en) * | 1992-05-04 | 1993-01-12 | Allergan, Inc. | Method for determining amount of medication in an implantable device |
US5300020A (en) * | 1991-05-31 | 1994-04-05 | Medflex Corporation | Surgically implantable device for glaucoma relief |
US5815234A (en) * | 1997-03-07 | 1998-09-29 | Dileo; Frank | Apparatus and method for viewing a surface through a mirror |
US6144508A (en) * | 1999-05-19 | 2000-11-07 | Bransome; Robert | Self-viewing device for eyes |
US6636701B1 (en) * | 1999-06-09 | 2003-10-21 | Jobin Yvon, Inc. | Ultraviolet imager system and method |
-
2001
- 2001-05-10 US US09/852,519 patent/US6982090B2/en not_active Expired - Fee Related
-
2004
- 2004-01-09 US US10/754,670 patent/US20040141151A1/en not_active Abandoned
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2582227A (en) * | 1948-12-27 | 1952-01-15 | Frank W Brady | Eye examining device having concave mirror |
US3677620A (en) * | 1967-11-20 | 1972-07-18 | Joseph Bettencourt | Corrective mirror assembly |
US3887800A (en) * | 1973-12-19 | 1975-06-03 | Minnesota Mining & Mfg | Personal care viewer |
US3949750A (en) * | 1974-10-07 | 1976-04-13 | Freeman Jerre M | Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same |
US4507585A (en) * | 1981-09-18 | 1985-03-26 | Hitachi, Ltd. | Beam-indexing color picture tube arrangement |
US4682867A (en) * | 1985-04-02 | 1987-07-28 | Gould Herbert L | Apparatus for the self-examination of the human eye |
US4750831A (en) * | 1986-05-23 | 1988-06-14 | Vega L Eduardo | Apparatus and method for self-examination of the eye and surrounding facial areas |
US4902124A (en) * | 1988-09-06 | 1990-02-20 | Roy Sr Frederick H | Cataract monitoring method and means |
US4959048A (en) * | 1989-01-17 | 1990-09-25 | Helix Medical, Inc. | Lacrimal duct occluder |
US4983846A (en) * | 1989-08-22 | 1991-01-08 | Arturo M. Rios | Portable fingerprint detection method and device |
US5300020A (en) * | 1991-05-31 | 1994-04-05 | Medflex Corporation | Surgically implantable device for glaucoma relief |
US5178635A (en) * | 1992-05-04 | 1993-01-12 | Allergan, Inc. | Method for determining amount of medication in an implantable device |
US5815234A (en) * | 1997-03-07 | 1998-09-29 | Dileo; Frank | Apparatus and method for viewing a surface through a mirror |
US6144508A (en) * | 1999-05-19 | 2000-11-07 | Bransome; Robert | Self-viewing device for eyes |
US6636701B1 (en) * | 1999-06-09 | 2003-10-21 | Jobin Yvon, Inc. | Ultraviolet imager system and method |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050232972A1 (en) * | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
US9463114B2 (en) | 2004-04-15 | 2016-10-11 | Mati Therapeutics Inc. | Punctal plug with active agent |
US20100040670A1 (en) * | 2004-04-15 | 2010-02-18 | Qlt Plug Delivery, Inc. | Drug delivery via ocular implant |
US20090118702A1 (en) * | 2004-07-02 | 2009-05-07 | Forsight Labs, Llc | Treatment Medium Delivery Device and Methods for Delivery of Such Treatment Mediums to the Eye Using such a Delivery Device |
US9180045B2 (en) | 2004-07-02 | 2015-11-10 | Mati Therapeutics Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
US7922702B2 (en) | 2004-07-02 | 2011-04-12 | Qlt Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
US9820884B2 (en) | 2004-07-02 | 2017-11-21 | Mati Therapeutics Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such delivery device |
US10610407B2 (en) | 2004-07-02 | 2020-04-07 | Mati Therapeutics Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such delivery device |
US20100004557A1 (en) * | 2005-03-18 | 2010-01-07 | Deborah Zelinsky | Method for diagnosis and treatment of processing difficulties, integration problems, imbalances and abnormal postures |
US7607777B2 (en) * | 2005-03-18 | 2009-10-27 | Deborah Zelinsky | Method for diagnosis and treatment of processing difficulties, integration problems, imbalances and abnormal postures |
US20090005702A1 (en) * | 2005-03-18 | 2009-01-01 | Deborah Zelinsky | Method for diagnosis and treatment of processing difficulties, integration problems, imbalances and abnormal postures |
US20090098584A1 (en) * | 2005-09-01 | 2009-04-16 | Bristol-Myers Squibb Company | Biomarkers and Methods for Determining Sensitivity to Vascular Endothelial growth factor Receptor-2 Modulators |
US10383817B2 (en) | 2006-03-31 | 2019-08-20 | Mati Therapeutics Inc. | Nasolacrimal drainage system implants for drug therapy |
US10300014B2 (en) | 2006-03-31 | 2019-05-28 | Mati Therapeutics Inc. | Nasolacrimal drainage system implants for drug therapy |
US10874606B2 (en) | 2006-03-31 | 2020-12-29 | Mati Therapeutics Inc. | Nasolacrimal drainage system implants for drug therapy |
US9168222B2 (en) | 2006-03-31 | 2015-10-27 | Mati Therapeutics Inc. | Nasolacrimal drainage system implants for drug therapy |
US7998497B2 (en) | 2006-03-31 | 2011-08-16 | Qlt Inc. | Nasolacrimal drainage system implants for drug therapy |
US9610194B2 (en) | 2006-03-31 | 2017-04-04 | Mati Therapeutics Inc. | Drug delivery methods, structures, and compositions for nasolacrimal system |
US11406592B2 (en) | 2006-03-31 | 2022-08-09 | Mati Therapeutics Inc. | Drug delivery methods, structures, and compositions for nasolacrimal system |
US8691265B2 (en) | 2006-03-31 | 2014-04-08 | Mati Therapeutics, Inc. | Drug delivery methods, structures, and compositions for nasolacrimal system |
US9849082B2 (en) | 2006-03-31 | 2017-12-26 | Mati Therapeutics Inc. | Nasolacrimal drainage system implants for drug therapy |
US8747884B2 (en) | 2006-03-31 | 2014-06-10 | Mati Therapeutics Inc. | Nasolacrimal drainage system implants for drug therapy |
US8795711B2 (en) | 2006-03-31 | 2014-08-05 | Mati Therapeutics Inc. | Drug delivery methods, structures, and compositions for nasolacrimal system |
US20070243230A1 (en) * | 2006-03-31 | 2007-10-18 | Forsight Labs, Llc | Nasolacrimal Drainage System Implants for Drug Therapy |
US20110066067A1 (en) * | 2006-12-07 | 2011-03-17 | Deborah Zelinsky | Methods for Diagnosis and Treatment of Processing Difficulties, Integration Problems, Imbalances and Abnormal Postures |
US9011361B2 (en) * | 2007-09-07 | 2015-04-21 | Mati Therapeutics Inc. | Lacrimal implant detection |
US10434009B2 (en) | 2007-09-07 | 2019-10-08 | Mati Therapeutics Inc. | Lacrimal implants and related methods |
US8702643B2 (en) | 2007-09-07 | 2014-04-22 | Mati Therapeutics, Inc. | Lacrimal implants and related methods |
US20090099626A1 (en) * | 2007-09-07 | 2009-04-16 | Qlt Plug Delivery, Inc. - Qpdi | Lacrimal implant detection |
US9445944B2 (en) | 2007-09-07 | 2016-09-20 | Mati Therapeutics Inc. | Lacrimal implants and related methods |
US8628792B2 (en) | 2007-09-07 | 2014-01-14 | Mati Therapeutics, Inc. | Drug cores for sustained release of therapeutic agents |
US8333726B2 (en) | 2007-09-07 | 2012-12-18 | Qlt Inc. | Lacrimal implants and related methods |
US11141312B2 (en) | 2007-09-07 | 2021-10-12 | Mati Therapeutics Inc. | Lacrimal implant detection |
US20090105749A1 (en) * | 2007-09-07 | 2009-04-23 | Qlt Plug Delivery, Inc. - Qpdi | Insertion and extraction tools for lacrimal implants |
US20090104243A1 (en) * | 2007-09-07 | 2009-04-23 | Qlt Plug Delivery, Inc. - Qpdi | Drug cores for sustained release of therapeutic agents |
US20090104248A1 (en) * | 2007-09-07 | 2009-04-23 | Qlt Plug Delivery, Inc. -Qpdi | Lacrimal implants and related methods |
US20090264861A1 (en) * | 2008-02-18 | 2009-10-22 | Qlt Plug Delivery, Inc. | Lacrimal implants and related methods |
US9216108B2 (en) | 2008-02-18 | 2015-12-22 | Mati Therapeutics Inc. | Lacrimal implants and related methods |
US9132088B2 (en) | 2008-04-30 | 2015-09-15 | Mati Therapeutics Inc. | Composite lacrimal insert and related methods |
US9764066B2 (en) | 2008-04-30 | 2017-09-19 | Mati Therapeutics Inc. | Composite lacrimal insert and related methods |
US9949942B2 (en) | 2008-05-09 | 2018-04-24 | Mati Therapeutics Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
US20090280158A1 (en) * | 2008-05-09 | 2009-11-12 | Qlt Plug Delivery, Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
US10238535B2 (en) | 2009-02-23 | 2019-03-26 | Mati Therapeutics Inc. | Lacrimal implants and related methods |
US20100274204A1 (en) * | 2009-02-23 | 2010-10-28 | Qlt Plug Delivery, Inc. | Lacrimal implants and related methods |
US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
US10632012B2 (en) | 2011-08-29 | 2020-04-28 | Mati Therapeutics Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
US9610271B2 (en) | 2011-08-29 | 2017-04-04 | Mati Therapeutics Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
WO2022241266A1 (en) * | 2021-05-14 | 2022-11-17 | Glaukos Corporation | Materials and methods for punctal plugs |
Also Published As
Publication number | Publication date |
---|---|
US6982090B2 (en) | 2006-01-03 |
US20020169409A1 (en) | 2002-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6982090B2 (en) | More easily visualized punctum plug configurations | |
JP5808833B2 (en) | Ophthalmic implant | |
Murphy et al. | Fundamentals of light microscopy and electronic imaging | |
EP0079930B1 (en) | Optical system | |
EP2503970B1 (en) | Single-fiber multi-spot laser probe for ophthalmic endoillumination | |
US6021344A (en) | Fluorescence scope system for dermatologic diagnosis | |
RU2547648C2 (en) | Finder system | |
FI20021477A (en) | Method and system for characterizing and mapping tissue lesions | |
EP1149555A2 (en) | Fluorescent endoscope apparatus | |
US20110190639A1 (en) | Bi-Spectral Peroperative Optical Probe | |
CA2669902A1 (en) | Illumination source comprising light emitting diodes for stained biological samples | |
JP2005078083A (en) | Light emitting diode illumination device for optical observation instrument such as stereo microscope or stereo surgical microscope in particular | |
JP7344211B2 (en) | illuminated cannula | |
JPH11514458A (en) | Darkfield ring light adapter | |
JP6716201B2 (en) | Optical filter system, fluorescence observation system and method for performing fluorescence observation | |
JP2012058732A (en) | Surgical fluorescence stereomicroscope | |
JP2000097859A (en) | Fluorescence observing method and device | |
JPH09508970A (en) | Diamond inspection | |
US6299310B1 (en) | Luminous intensity detection and control system for slit lamps and slit lamp projections | |
US4639837A (en) | Illuminating optical system for high magnification endoscopes | |
US7298487B2 (en) | Method and apparatus for measuring light reflections of an object | |
JPH03266809A (en) | Vertical fluorescent microscope for ultraviolet range | |
RU2158961C1 (en) | Videospectral comparator for control of securities and documents | |
Carlsson | Light microscopy | |
JPS649608B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |